Tetracaine derivatives for catecholaminergic polymorphic ventricular tachycardia: New drugs for correction of diastolic Ca²⁺ leak?

Heart Rhythm. 2018 Apr;15(4):587-588. doi: 10.1016/j.hrthm.2018.01.022. Epub 2018 Feb 2.

Authors

Héctor H Valdivia¹, Carmen R Valdivia²

Affiliations

¹ Division of Cardiovascular Medicine, Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin. Electronic address: hvaldivia@wisc.edu.
² Division of Cardiovascular Medicine, Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin.

No abstract available

Publication types

Editorial
Comment

MeSH terms

Diastole
Humans
Ryanodine Receptor Calcium Release Channel
Tachycardia, Ventricular*
Tetracaine*

Substances

Ryanodine Receptor Calcium Release Channel
Tetracaine

Supplementary concepts

Polymorphic catecholergic ventricular tachycardia

Grants and funding